China Pharmaceuticals and Healthcare Report Q1 2015

Business Monitor International
December 17, 2014
204 Pages - SKU: BMI5416301
Countries covered: China

China Pharmaceuticals and Healthcare Report Q1 2015

BMI View: Improvements in intellectual property protection, an ageing population and increasing accessto healthcare will drive the robust growth of China's pharmaceutical market. This will attract foreign drugmanufacturers despite the downside risks of pharmaeconomics and the government's crackdown on illegalpractices.

Headline Expenditure Projections

Pharmaceuticals: CNY532.4bn (USD86.6bn) in 2013 to CNY616.1bn (USD100.6bn) in 2014; +15.7%in local currency and +16.1% in US dollar terms.

Healthcare: CNY3,230.8bn (USD525.4bn) in 2013 to CNY3,733.1bn (USD609.2bn) in 2014; +15.6% inlocal currency terms and +15.9% in US dollar terms. Forecast has been upgraded from Q414 due toupgraded growth in private health expenditure.



More Prescription Drugs reports by Business Monitor International

Tanzania Pharmaceuticals and Healthcare Report Q2 2015 by Business Monitor International
Tanzania Pharmaceuticals and Healthcare Report Q2 2015BMI View: Tanzania's pharmaceutical market will continue to see growth with the continuing expansion ofthe country's National Health Insurance ...
Singapore Pharmaceuticals and Healthcare Report Q2 2015 by Business Monitor International
Singapore Pharmaceuticals and Healthcare Report Q2 2015BMI View: Singapore will remain a highly attractive manufacturing base for international pharmaceuticalcompanies due to minimal levels of operational ...
Poland Pharmaceuticals and Healthcare Report Q2 2015 by Business Monitor International
Poland Pharmaceuticals and Healthcare Report Q2 2015BMI View: The Polish pharmaceutical market is heavily dependent on public healthcare spending; anynegative economic developments will have an ...
Peru Pharmaceuticals and Healthcare Report Q2 2015 by Business Monitor International
Peru Pharmaceuticals and Healthcare Report Q2 2015BMI View: Longstanding trade agreements with the US and EU, along with efficient regulations for qualitycontrol will continue to ...
See all reports like this >>

More China Prescription Drugs reports

Pharmaceuticals Markets in China by Asia Market Information & Development Company
Pharmaceuticals Markets in ChinaChina's demand for Pharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production ...
Osteoporosis Drugs Markets in China by Asia Market Information & Development Company
Osteoporosis Drugs Markets in ChinaChina's demand for Osteoporosis Drugs has grown at a fast pace in the past decade. In the next decade, both production ...
Mental Illness Drugs Markets in China by Asia Market Information & Development Company
Mental Illness Drugs Markets in ChinaChina's demand for Mental Illness Drugs has grown at a fast pace in the past decade. In the next decade, ...
Hypertension Drugs Markets in China by Asia Market Information & Development Company
Hypertension Drugs Markets in ChinaChina's demand for Hypertension Drugs has grown at a fast pace in the past decade. In the next decade, both production ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!